Tilray Brands 2HQ0.DE (XETRA) Q2 revenue beats Apr 01 2026: catalysts ahead

Tilray Brands, Inc. (2HQ0.DE stock) reported a Q2 revenue beat on Apr 01 2026, with record net revenue of $217.50 million and EPS roughly in line with estimates. The XETRA-listed share closed at €5.33, up 2.11%, as investors parsed mixed operational growth and continued negative EPS. This earnings spotlight explains the numbers, links them to valuation and technicals, and highlights where analysts will focus next for 2HQ0.DE stock

Earnings snapshot and immediate market reaction

Tilray Brands delivered record Q2 net revenue of $217.50 million, about 3.38% above consensus according to public reports source. The company reported an EPS loss near $0.02, matching expectations and keeping trailing EPS metrics deeply negative. The XETRA listing moved to €5.33 on the close, with intraday range €5.22–€6.19 and volume 26,185 shares, showing above-average interest versus the 50-day average of 3,998.

Financials, valuation and what the ratios show

Key trailing metrics underline the recovery challenge: reported EPS is -20.48, PE is -0.27, and price-to-book is 0.44, indicating the market values the stock below book. Tilray’s current ratio is 2.81, and cash per share is €2.64, supporting short-term liquidity. Revenue per share TTM is 7.59, but net income per share remains -19.10, keeping free cash flow negative at -0.62 per share.

Meyka AI rates 2HQ0.DE with a score out of 100: grade and model forecast

Meyka AI rates 2HQ0.DE with a score of 66.52 out of 100 (Grade: B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a near-term monthly price of €5.92 and a 12‑month projection of €44.94, implying a +11.06% short-term upside and an implied +743.46% vs current €5.33 for the 12‑month figure. Forecasts are model-based projections and not guarantees.

Technical view and trading signals for 2HQ0.DE stock

Technically, the stock sits below both the 50‑day average (€6.41) and the 200‑day average (€8.29), signalling a medium-term downtrend. Momentum indicators show RSI 45.42 and MACD slightly negative, while ADX at 65.24 signals a strong trend, currently downward. Bollinger Bands ran €5.23–€6.53 today; a sustained move above €6.53 would be a first bullish trigger for traders.

Sector context, peers and risks

Tilray operates in Healthcare’s drug manufacturers and beverage/wellness subsegments where average sector multiples remain higher than Tilray’s. The Healthcare sector has been mixed YTD; investors watch regulatory shifts, U.S. cannabis policy, and consumer beverage performance. Primary risks for 2HQ0.DE stock include ongoing negative earnings, inventory turns (days of inventory 171.50), and interest coverage weakness at -62.14.

Analyst takeaways and realistic price targets

With no broad sell‑side consensus published for the XETRA ticker, we frame practical targets. A conservative 12‑month price target is €9.00 based on recovery to mid‑cycle multiples and improved margin execution. A moderate target is €7.50 and a high‑scenario target aligned with Meyka’s aggressive model is €44.94, though the latter requires material margin and revenue expansion. Downside support sits near the 52‑week low €2.80; stop levels below €4.00 would limit risk for active traders.

Final Thoughts

Tilray Brands (2HQ0.DE stock) delivered a revenue beat on Apr 01 2026 but continues to show negative EPS and stretched operating margins. The share closed at €5.33 with above‑average volume, and valuation metrics such as price‑to‑book 0.44 and negative PE reflect market caution. Meyka AI’s near-term monthly forecast of €5.92 suggests modest upside of 11.06%, while the longer-term model projects €44.94, an optimistic scenario that would require major operational improvements and broader sector re-rating. Our technical read shows the stock beneath both 50‑ and 200‑day averages, with a catalyst pathway via sustained margin improvement, regulatory clarity, or stronger beverage growth. Short‑term traders can watch a breakout above €6.53; longer‑term holders should monitor cash conversion and earnings recovery. Remember, Meyka AI is an AI‑powered market analysis platform; forecasts and the Meyka grade are informational and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.